|
Market Closed -
Nasdaq Stockholm
02:00:00 15/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1770 SEK | +1.14% |
|
+3.81% | -1.39% |
| 22/05 | XP Chemistries reports Q1 operating profit of SEK -3.07 mln | RE |
| 22/05 | XP Chemistries AB Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 55.57M 5.84M 5.05M 4.74M 4.31M 8.11M 559M 8.24M 21.73M 280M 21.94M 21.46M 930M | P/E 2024 |
-1.48x | P/E 2025 | -5.22x |
|---|---|---|---|---|---|
| Enterprise Value | 40.35M 4.24M 3.66M 3.44M 3.13M 5.89M 406M 5.98M 15.78M 203M 15.93M 15.58M 675M | EV / Sales 2024 |
43.7x | EV / Sales 2025 | 126x |
| Free-Float |
40.38% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.14% | ||
| 1 week | +3.81% | ||
| Current month | +5.36% | ||
| 1 month | +6.95% | ||
| 3 months | +0.85% | ||
| 6 months | -1.67% | ||
| Current year | -1.39% |
| 1 week | 0.16 |  | 0.18 |
| 1 month | 0.16 | | 0.18 |
| Current year | 0.15 | | 0.2 |
| 1 year | 0.15 | | 0.33 |
| 3 years | 0.03 | | 0.54 |
| 5 years | 0.03 | | 4.5 |
| 10 years | 0.03 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 43 | 01/01/2021 |
Anders Frejdh
DFI | Director of Finance/CFO | 52 | 01/01/2021 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Armando Córdova
CHM | Chairman | 56 | 01/01/2015 |
Jonas Hafrén
BRD | Director/Board Member | 57 | 01/01/2021 |
Samson Afewerki
BRD | Director/Board Member | 41 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/4/24 | Buy | Chief Executive Officer | 20,000 | 0.0136% | ||
| 15/4/24 | Buy | Chief Executive Officer | 30,000 | 0.0204% | ||
| 15/4/24 | Buy | Chief Executive Officer | 50,000 | 0.0340% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +3.81% | -40.20% | -64.60% | 5.84M | |
| -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | |
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | |
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | |
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | |
| +0.16% | +3.87% | +16.89% | +73.73% | 172B | |
| Average | -0.91% | +1.00% | +20.42% | +31.94% | 359.52B | |
| Weighted average by Cap. | -1.36% | +0.32% | +39.09% | +61.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 284K 29.86K 25.79K 24.23K 22.04K 41.43K 2.86M 42.12K 111K 1.43M 112K 110K 4.75M | 327K 34.43K 29.73K 27.94K 25.41K 47.78K 3.29M 48.56K 128K 1.65M 129K 126K 5.48M |
| Net income | -7.13M -750K -648K -609K -554K -1.04M -71.73M -1.06M -2.79M -35.92M -2.82M -2.76M -119M | -8.52M -896K -774K -727K -661K -1.24M -85.68M -1.26M -3.33M -42.9M -3.36M -3.29M -143M |
| Net Debt | -2.15M -226K -195K -183K -167K -313K -21.57M -318K -839K -10.8M -847K -829K -35.9M | -15.23M -1.6M -1.38M -1.3M -1.18M -2.22M -153M -2.26M -5.95M -76.67M -6.01M -5.88M -255M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | SEK 0.1770 | +1.14% | 534,207 |
| 13/08/26 | SEK 0.1750 | +3.55% | 340,448 |
| 12/08/26 | SEK 0.1690 | -0.59% | 148,384 |
| 11/08/26 | SEK 0.1700 | 0.00% | 52,597 |
| 10/08/26 | SEK 0.1700 | -0.29% | 31,379 |
- Stock Market
- Stocks
- XPC Stock
Select your edition
All financial news and data tailored to specific country editions
